Related Experiment Video

Updated: Dec 19, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in

You Shang1, Chun Pan2, Xianghong Yang3

  • 1Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Annals of Intensive Care
|June 8, 2020
PubMed

Insights

Expert consensus provides guidance for managing critically ill patients with coronavirus disease 2019 (COVID-19). Recommendations cover personnel protection, organ support, and therapies, emphasizing dynamic monitoring and supportive care due to lack of targeted treatments.

Area of Science:

  • Intensive Care Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • The COVID-19 pandemic has overwhelmed critical care resources globally.
  • Urgent need for expert guidance on managing severe COVID-19 cases.

Purpose of the Study:

  • To develop evidence-based and expert-opinion recommendations for the critical care of COVID-19 patients.
  • To provide trustworthy guidance for front-line medical personnel.

Main Methods:

  • A Delphi-like method involving 5 rounds of expert seminars and discussions.
  • 16 front-line critical care experts in China contributed based on their expertise.
  • Statements were developed using available clinical evidence and expert consensus.

Main Results:

  • A comprehensive document with 46 statements on COVID-19 critical care was generated.
  • Recommendations included personnel protection, etiological treatment, organ support, and patient transport.
  • 5 strong recommendations (Grade 1), 21 weak recommendations (Grade 2), and 20 expert opinions were established with strong agreement.

Conclusions:

  • No targeted therapies are currently available for COVID-19.
  • Dynamic monitoring and supportive treatment are crucial for organ function recovery.
  • Expert consensus provides essential guidance for critical care management during the pandemic.
Abstract

Keywords:
COVID-19Critical careExpert statement

More Related Videos

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
153
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
660
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
355
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
191
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
637
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
434